SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-23-071885
Filing Date
2023-12-20
Accepted
2023-12-20 16:08:54
Documents
1
Period of Report
2023-12-19

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3790
  Complete submission text file 0000950170-23-071885.txt   5197
Mailing Address 103 CARNEGIE CENTER SUITE 300 PRINCETON NJ 08540
Business Address 103 CARNEGIE CENTER SUITE 300 PRINCETON NJ 08540 609-649-9272
Acasti Pharma Inc. (Issuer) CIK: 0001444192 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 11 MAACKA DRIVE HOLMDEL NJ 07733
Business Address
Kavuru Vimal (Reporting) CIK: 0001697184 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35776 | Film No.: 231501425